S100A8 and cardiovascular disorder: Furthermore, systemic markers of inflammation and acute phase reactants have been shown to be associated prospectively with ACS risk, and part of the beneficial effects of aspirin on cardiovascular disease risk appeared to be directly related to its anti-inflammatory.[52] Thus, it is possible that CagA-positive H pylori infection may increase the risk of ACS through the induction of a more severe inflammatory response.